Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP

scientific article published on 01 August 2018

Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/EN.2018-00279
P932PMC publication ID6456925
P698PubMed publication ID29893816

P50authorChad VezinaQ42876741
P2093author name stringJulia F Charles
Robert J Lipinski
Laura L Hernandez
Samantha R Weaver
Cynthia Xie
Hannah P Fricke
P2860cites workLrp5 functions in bone to regulate bone massQ24615653
FOXO1 orchestrates the bone-suppressing function of gut-derived serotoninQ24632551
Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating MiceQ44590717
Maternal Fluoxetine Treatment in the Postpartum Period: Effects on Platelet Serotonin and Plasma Drug Levels in Breastfeeding Mother-Infant PairsQ44640562
Effects of chronic fluoxetine in animal models of anxiety and depression.Q44845253
Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growthQ45147936
Feeding 5-hydroxy-l-tryptophan during the transition from pregnancy to lactation increases calcium mobilization from bone in ratsQ45209624
The Selective Serotonin Reuptake Inhibitor Fluoxetine Directly Inhibits Osteoblast Differentiation and Mineralization During Fracture Healing in Mice.Q46276238
Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiencyQ46412245
Characterization of mammary-specific disruptions for Tph1 and Lrp5 during murine lactationQ47199203
Pregnancy and lactation increase vitamin D-dependent intestinal membrane calcium adenosine triphosphatase and calcium binding protein messenger ribonucleic acid expression.Q47777401
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.Q51009028
Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice.Q53135537
Parathyroid hormone-related protein increases cAMP production in mammary epithelial cellsQ72961187
Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell linesQ84580071
Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactationQ24645591
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenumQ24653502
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
The mouse forced swim testQ28259192
FGF-21 and skeletal remodeling during and after lactation in C57BL/6J mice.Q30371088
Serotonin signalling in the gut--functions, dysfunctions and therapeutic targetsQ33724343
Serotonin transport and metabolism in the mammary gland modulates secretory activation and involutionQ33736087
The two faces of serotonin in bone biologyQ34191657
Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signalsQ34253136
Relationship between use of antidepressants and risk of fractures: a meta-analysisQ34277620
Peripheral serotonin regulates maternal calcium trafficking in mammary epithelial cells during lactation in miceQ34317625
Increased PTHrP and Decreased Estrogens Alter Bone Turnover but Do Not Reproduce the Full Effects of Lactation on the SkeletonQ34392597
Serotonin regulates calcium homeostasis in lactation by epigenetic activation of hedgehog signalingQ34422475
Enhanced responsiveness to selective serotonin reuptake inhibitors during lactationQ35092485
A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnoverQ35832437
Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of actionQ35893903
Factors associated with bone mineral density in healthy African women.Q36041583
Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistanceQ36153043
Parathyroid hormone-related protein: an updateQ36201545
Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cellsQ36861448
Mammary-specific ablation of the calcium-sensing receptor during lactation alters maternal calcium metabolism, milk calcium transport, and neonatal calcium accrualQ37110969
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.Q37163219
Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactationQ37184468
Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect.Q37317822
DNA methylation of E-cadherin is a priming mechanism for prostate development.Q37686939
Antidepressant Drugs and Breastfeeding: A Review of the LiteratureQ37801369
Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and functionQ38319110
SSRI use during pregnancyQ38597107
Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning RecoveryQ38737740
Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in miceQ39673212
Effects of antidepressants on postmenopausal bone loss - A 5-year longitudinal study from the OSTPRE cohortQ39766108
Mean Age of Mothers is on the Rise: United States, 2000-2014.Q40039112
Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.Q40536036
Irreversible Deterioration of Cortical and Trabecular Microstructure Associated With BreastfeedingQ40543803
Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling.Q42615548
P4510describes a project that usesImageJQ1659584
P433issue8
P921main subjectfluoxetineQ422244
P304page(s)2850-2862
P577publication date2018-08-01
P1433published inEndocrinologyQ3054009
P1476titlePeripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP
P478volume159